NIH-funded research R01 grant

Investigating how tyrosine metabolism affects tuberculosis progression

Official title: The role of tyrosine metabolism in tuberculosis pathogenesis

Funded at University of California, San Francisco · NIH-11007255 · Data updated 2026-11-12

This study is looking at how changes in a specific part of your body's metabolism might affect the progression of tuberculosis, and it's for people with TB or those at risk, to help find new ways to treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 21, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$784,531
NIH project number5R01AI175614-03
Project IDNIH-11007255 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been exposed to tuberculosis or are at risk of developing the disease, particularly those with genetic variations affecting tyrosine metabolism.

Less likely to help

Patients who are not at risk for tuberculosis or do not have any metabolic disorders related to tyrosine metabolism may not benefit from this research.

What this research studies

This research explores the role of tyrosine metabolism in the progression of tuberculosis (TB) disease. It examines how Mycobacterium tuberculosis (Mtb) alters the metabolism of immune cells, particularly focusing on the enzyme Fumarylacetoacetate hydrolase (FAH) and its impact on susceptibility to TB. By analyzing blood samples from individuals with TB and those at risk, the study aims to uncover metabolic changes that could inform new treatment strategies. The research employs genetic analysis and metabolic profiling to understand the relationship between tyrosine levels and TB disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches that target metabolic pathways to prevent or treat tuberculosis.

How similar studies have gone: Previous research has indicated that metabolic interventions may play a significant role in managing tuberculosis, suggesting that this approach has potential based on earlier findings.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Suliman, Sara — University of California, San Francisco
  • Study coordinator: Suliman, Sara

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.